Viewing Study NCT03777059


Ignite Creation Date: 2025-12-24 @ 2:54 PM
Ignite Modification Date: 2026-02-28 @ 5:52 PM
Study NCT ID: NCT03777059
Status: COMPLETED
Last Update Posted: 2021-07-09
First Post: 2018-12-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: 12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine
Sponsor: Allergan
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Episodic Migraine View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Migraine View
None Aura View